Page 93 - Read Online

change in ferumoxytol‑enhanced magnetic resonance imaging signal 58. Hasan D, Hashimoto T, Kung D, Macdonald RL, Winn HR, Heistad D.
suggests unstable human cerebral aneurysm: a pilot study. Stroke Upregulation of cyclooxygenase‑2 (COX‑2) and microsomal
2012;43:3258‑65. prostaglandin E2 synthase‑1 (mPGES‑1) in wall of ruptured human
52. Hasan DM, Chalouhi N, Jabbour P, Dumont AS, Kung DK, cerebral aneurysms: preliminary results. Stroke 2012;43:1964‑7.
Magnotta VA, Young WL, Hashimoto T, Richard Winn H, Heistad D. 59. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological
Evidence that acetylsalicylic acid attenuates inflammation in the and pathological effects in the cardiovascular system. Am J Physiol
walls of human cerebral aneurysms: preliminary results. J Am Heart Cell Physiol 2007;292:C82‑97.
Assoc 2013;2:e000019. 60. Peña Silva RA, Kung DK, Mitchell IJ, Alenina N, Bader M,
53. Chalouhi N, Jabbour P, Magnotta V, Hasan D. The emerging role of Santos RA, Faraci FM, Heistad DD, Hasan DM. Angiotensin 1‑7
ferumoxytol‑enhanced MRI in the management of cerebrovascular reduces mortality and rupture of intracranial aneurysms in mice.
lesions. Molecules 2013;18:9670‑83. Hypertension 2014;64:362‑8.
54. Hasan DM, Chalouhi N, Jabbour P, Magnotta VA, Kung DK, 61. Aoki T, Kataoka H, Nishimura M, Ishibashi R, Morishita R,
Young WL. Imaging aspirin effect on macrophages in the wall Miyamoto S. Regression of intracranial aneurysms by simultaneous
of human cerebral aneurysms using ferumoxytol‑enhanced MRI: inhibition of nuclear factor‑κB and Ets with chimeric decoy
preliminary results. J Neuroradiol 2013;40:187‑91. oligodeoxynucleotide treatment. Neurosurgery 2012;70:1534‑43.
55. Gounis MJ, Vedantham S, Weaver JP, Puri AS, Brooks CS, 62. Starke RM, Chalouhi N, Jabbour PM, Tjoumakaris SI, Gonzalez LF,
Wakhloo AK, Bogdanov AA Jr. Myeloperoxidase in human Rosenwasser RH, Wada K, Shimada K, Hasan DM, Greig NH,
intracranial aneurysms: preliminary evidence. Stroke Owens GK, Dumont AS. Critical role of TNF‑α in cerebral aneurysm
2014;45:1474‑7. formation and progression to rupture. J Neuroinflammation
56. DeLeo MJ 3rd, Gounis MJ, Hong B, Ford JC, Wakhloo AK, 2014;11:77.
Bogdanov AA Jr. Carotid artery brain aneurysm model: in vivo
molecular enzyme‑specific MR imaging of active inflammation in a Cite this article as: Dooley SA, Hudson JS, Hasan DM. Inflammation in
pilot study. Radiology 2009;252:696‑703. human cerebral aneurysms: pathogenesis, diagnostic imaging, genetics, and
57. Hasan DM, Mahaney KB, Brown RD Jr, Meissner I, Piepgras DG, therapeutics. Neuroimmunol Neuroinflammation 2015;2(2):77-85.
Huston J, Capuano AW, Torner JC. Aspirin as a promising agent Source of Support: Nil. Conflict of Interest: No.
for decreasing incidence of cerebral aneurysm rupture. Stroke
2011;42:3156‑62. Received: 14-09-2014; Accepted: 30-09-2014

Neuroimmunol Neuroinflammation | Volume 2 | Issue 2 | April 15, 2015 85